Applied Biosystems Solutions for Cancer Research

Applied Biosystems solutions have the answers to big oncology questions

What if we could prevent tumor formation? Detect cancer without invasive biopsies? Or cure even the most aggressive cancers? For those willing to ask the big questions in cancer research, Applied Biosystems solutions are where the answers come together. We deliver the accuracy, speed, and breadth of solutions you need to facilitate your oncology research from discovery through delivery of life-changing treatments.

Understanding cancer and neurodegeneration with genetic biomarkers eBook

We are entering the era of precision medicine, with the goal to optimize the effectiveness and safety of therapies by matching the treatment to the biology for which the treatment was designed. Much work has been done to identify measurable molecular characteristics that can be used for the diagnosis, prognosis, and safety of treatments that provide minimal discomfort to the patient but maximize the chance of success.

 

Download our latest eBook to learn about the significance of DNA and RNA biomarkers in cancer and neurodegeneration and how genetic analysis technologies can support research in these areas.
 

Current Time 0:00
Duration 0:40
Loaded: 0%
Stream Type LIVE
Remaining Time 0:40
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Analyzing methylated DNA in colon tumor samples for translational research

    Colon cancer, also known as colorectal cancer, is one of the most common types of cancer globally. Download this app note for detailed insights into methylation, quantitative methylation analysis techniques, and how a streamlined workflow can enhance efficiency in your research process.

    Understanding cancer with precision genomics

    Applied Biosystems solutions include a comprehensive range of tools that are extensively utilized in cancer research. In this eBook, learn how genomics can be incorporated into cancer research, from decoding cancer signatures from extracellular vesicles to using circulating tumor DNA to predict survival rates.
     

    Advancing cancer research using genetic analysis tools

    New advances in gold-standard genetic technologies such as qPCR, CE sequencing, and microarrays continue to drive fundamental and applied discoveries in oncology. More recent technologies such as NGS, microfluidic dPCR, and others are enabling researchers to pursue new territory with greater sensitivity, precision, and speed. This eBook explores how genetic technologies have enabled some of the most recent and exciting discoveries in several areas of cancer research. 
     

    Customer spotlights

    Harald Bartsch

    Clinical Pathologist
    Gemeinschaftspraxis für Pathologie, Traunstein

    Dr. Harald Bartsch walks you through his comprehensive workflow for DNA/RNA extraction and analysis.

    headshot

    Olga Vera

    Junior Principal Investigator
    Epigenetics Laboratory
    La Paz University Hospital

    Olga Vera uses both digital and qPCR technologies to explore non-genetic alterations in melanoma.

    headshot

    Atocha Romero

    Director, Liquid Biopsy Laboratory
    Hospital Universitario Puerta di Hierro


    Dr. Romero and her team hope to utilize digital PCR technology to eventually develop effective screening for lung cancer.
     

    headshot

    Tata Medical Team

    Tata Medical Center
    Kolkata


    Dr. Col. Deepak Mishra and his team of researchers share how Applied Biosystems technologies enable their research on acute leukemias.

    headshot

    Francis Barany

    Professor, Microbiology
    Weill Cornell Medicine

    Dr. Barany discusses his research into new liquid biopsy methods that use cost-efficient and scalable technology, in order to make cancer detection more accessible.

    headshot

    Kristi Baker

    Associate Professor
    University of Alberta

    Dr. Kristi Baker shares how her lab uses both animal and human models for their research into colon cancer, in order to close the gap between bench and bedside.

    headshot

    Sheri Olson

    Vice President and General Manager
    Human Identification
    Thermo Fisher Scientific

    Meet Sheri Olson and learn about her journey from a curious kid to one of the history-making scientists who studied and patented the BRCA 1 breast cancer gene.
     

    headshot

    Lanbo Xiao

    Research Investigator
    Michigan Center for Translational Pathology
    University of Michigan

    Meet Lanbo Xiao, a researcher using TaqMan Gene Expression assays to differentiate between aggressive and non-aggressive prostate cancer.
     

    headshot

    Derek McMahon

    Postdoctoral Fellow
    University of Pennsylvania


    Derek McMahon, PhD, explains how bitter compounds, such as quinine, have the potential to act as therapies for multiple diseases, including cancer.
     

    headshot

    Featured blog posts

    DNA & RNA biomarkers

    Advances in analytical technologies to discover and probe nucleic acid biomarkers can potentially enable us to overcome many challenges in cancer research.

    Advances in lung cancer & glioblastoma research

    We spoke to two experts in the field of liquid biopsy to learn more about the potential of circulating tumor DNA in monitoring lung cancer and glioblastoma.

    Liquid biopsy and cancer

    Liquid biopsy and cancer

    Cancer researchers like Dr. Atocha Romero are allowing us to determine potentially effective use of liquid biopsy in cancer diagnosis and management. We spoke with her to learn more about the challenges and opportunities involved in this approach.

    The potential of cfDNA
    Related pages

    QuantStudio Absolute Q Digital PCR System

    SeqStudio Flex Genetic Analyzers

    marketing banner

    For Research Use Only. Not for use in diagnostic procedures.